Characterization of Gαs and Gαolf activation by catechol and non-catechol dopamine D1 receptor agonists
A. M. Nguyen, A. Semeano, V. Quach, A. Inoue, D. E. Nichols, H. Yano
This study evaluates how different dopamine D1 receptor agonists activate Gαs and Gαolf, revealing region-specific pharmacological profiles with implications for targeted drug development.
bioRxiv · Oct 3, 2023 · PreprintPharmacology & Toxicology